Eris Biotech
Our drugs engage the immune system to fight tumors
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma. Eris Biotech is a Y Combinator company (Winter 2024). YC-listed status: Active.
- Website
- erisbio.com
- Location
- Lehi, UT, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Links
- Y Combinator profileycombinator